These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2318253)

  • 1. Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70.
    Grohmann U; Ullrich SJ; Mage MG; Appella E; Fioretti MC; Puccetti P; Romani L
    Eur J Immunol; 1990 Mar; 20(3):629-36. PubMed ID: 2318253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R; Graziano RF; Green WR
    J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level.
    Grohmann U; Puccetti P; Romani L; Binaglia L; Bianchi R; Belladonna ML; Ullrich SJ; Appella E; Fioretti MC
    Int J Cancer; 1992 Sep; 52(3):372-7. PubMed ID: 1399112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic properties of retroviral protein P15E from drug-treated murine mastocytoma P815.
    Grohmann U; Fioretti MC; Binaglia L; Belladonna ML; Bianchi R; Puccetti P
    Int J Cancer; 1993 Sep; 55(2):344-50. PubMed ID: 7690350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine tumor.
    Grohmann U; Puccetti P; Belladonna ML; Fallarino F; Bianchi R; Binaglia L; Sagakuchi K; Mage MG; Appella E; Fioretti MC
    J Immunol; 1995 May; 154(9):4630-41. PubMed ID: 7722315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
    Stackpole CW; Demsey A
    Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.
    Kern DE; Klarnet JP; Cheever MA; Greenberg PD
    Cancer Res; 1990 Oct; 50(19):6256-63. PubMed ID: 2144789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of a unique tumor antigen of radiation leukemia virus-induced leukemia B6RV2: its relation to MuLV gp70 of xenotropic class.
    Nakayama E; Uenaka A; DeLeo AB; Stockert E; Obata Y; Ueda R; Inui Y
    J Immunol; 1986 May; 136(9):3502-7. PubMed ID: 3007622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus.
    Rosato A; Dalla Santa S; Zoso A; Giacomelli S; Milan G; Macino B; Tosello V; Dellabona P; Lollini PL; De Giovanni C; Zanovello P
    Cancer Res; 2003 May; 63(9):2158-63. PubMed ID: 12727834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection.
    Jiang D; Flyer DC
    J Immunol; 1992 Feb; 148(3):974-80. PubMed ID: 1730885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo.
    Romani L; Fioretti MC; Bianchi R; Nardelli B; Bonmassar E
    J Natl Cancer Inst; 1982 May; 68(5):817-22. PubMed ID: 7040772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosensitivity and histocompatibility antigens in drug-altered leukemic cells.
    Nicolin A; Franco P; Testorelli C; Goldin A
    Cancer Res; 1976 Jan; 36(1):222-7. PubMed ID: 1248001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous retroviral gp70 genes of the murine lymphoma L5178Y: analysis of restriction fragment polymorphism upon induction of drug-mediated immunogenicity.
    Grohmann U; Belladonna ML; Allegrucci M; Silla S; Schiaffella E; Fioretti MC; Puccetti P
    Viral Immunol; 1994; 7(4):155-67. PubMed ID: 7576030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. II. Altered gp70 display and production of noninfectious virus particles by an insusceptible variant tumor.
    Green WR; Brown MA
    Eur J Immunol; 1983 Nov; 13(11):871-7. PubMed ID: 6196207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor immunity against CT26 colon tumor in mice immunized with plasmid DNA encoding beta-galactosidase fused to an envelope protein of endogenous retrovirus.
    Takeda J; Sato Y; Kiyosawa H; Mori T; Yokoya S; Irisawa A; Miyata M; Obara K; Fujita T; Suzuki T; Kasukawa R; Wanaka A
    Cell Immunol; 2000 Aug; 204(1):11-8. PubMed ID: 11006013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of immunogenic B16 melanoma-associated antigens.
    Johnston D; Schachne JP; Bystryn JC
    J Biol Response Mod; 1987 Apr; 6(2):108-20. PubMed ID: 3585408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location of tumoral antigens in L5178Y murine lymphoma cells.
    Ramos-Damián ME; Gómez-Estrada H; Hernández-Delgado J; Tapia-Arizmendi L; Feria-Velasco A
    Arch Invest Med (Mex); 1980; 11(3):425-34. PubMed ID: 7469659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-frequency generation of altered Mr 70,000 env glycoproteins in N-methyl-N'-nitro-N-nitrosoguanidine-treated murine tumor cells.
    Altevogt P; Apt D
    Cancer Res; 1988 Mar; 48(5):1137-42. PubMed ID: 3342395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.